It's Time to Bail Out Seniors Trapped in the Medicare Donut Hole!

American Journal of Medicine

Volumn 122, Issue 7, 2009, Pages 595-596

  Dalen, James E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

AGED; CHRONIC DISEASE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; GERIATRIC CARE; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LAW; LOWEST INCOME GROUP; MEDICARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL;

AGED; DRUG INDUSTRY; HUMANS; MEDICARE PART D; MEDICATION ADHERENCE; PRESCRIPTION DRUGS; UNITED STATES;

EID: 67649792254     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.03.016     Document Type: Editorial

References (20)

1. Kaiser Family Foundation, the Medicare prescription drug benefit fact sheet, March, 2009. http://www,kff,org/medicare/upload/7044_09.pdf Last accessed March 15, 2009.
2. Steinberg E.P., Guiterrez B., Momani A., et al. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Affairs 19 (2000) 198-211
3. Paez K.A., Zhao L., and Hwang W. Rising out-of-pocket spending for chronic conditions: A ten-year trend. Health Affairs 28 (2009) 15-25
4. Masoudi F.A., Baillie C.A., Wang Y., et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med 165 (2005) 2069-2076
5. Dalen J.E., and Hartz D.J. Medicare prescription drug coverage: A very long wait for a very modest benefit. Am J Med 118 (2005) 325-329
6. Iglehart J.K. Medicare and drug pricing. N Engl J Med 348 (2003) 1590-1597
7. House committee on oversight and government reform, July, 2008. http://www.medicarerights.org/pdf/072408_PrechtTestimonyonPartD.pdf Last accessed April 23, 2009.
8. Altman D.E. The new Medicare prescription-drug legislation. N Engl J Med 350 (2004) 9-10
9. Schneeweiss S., Patrick A.R., Pedan A., et al. The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Affairs 28 (2009) w305-w316
10. Zhang Y., Donohue J.M., Newhouse J.P., et al. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Affairs 28 (2009) w317-w325
11. Kaiser Family Foundation, The Medicare Part D coverage gap: Costs and consequences in 2007. August 2008. http://www.kff.org/medicare/upload/7811.pdf Last accessed March 15, 2009.
12. Center for Studying Health System Change, More nonelderly Americans dace problems affording prescription drugs. January, 2009. http://www.hschange.com/CONTENT/1039/ Last accessed March 17, 2009.
13. Rector T.S., and Venus P.J. Do drug benefits help Medicare beneficiaries afford prescribed drugs?. Health Affairs 23 (2004) 213-222
14. Christian-Herman J., Emons M., and George D. Effects of generic-only drug coverage in a Medicare HMO. Health Affairs 23 (2004) w455-w468
15. Hsu J., Price M., and Huang J. Unintended consequences of caps on Medicare drug benefits. N Engl J Med 354 (2006) 2349-2359
16. Tamblyn R., Laprise R., Hanley J.A., et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285 (2001) 421-429
17. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289 (2003) 2560-2571
18. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
19. Moeller J.F., Miller G.E., and Banthin J.S. Looking inside the nation's medicine cabinet: Trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001. Health Affairs 23 (2004) 217-225
20. Anderson G.F., Shea D.G., Hussey P.S., et al. Doughnut holes and price controls. Health Affairs 23 (2004) 396-404